A number of other research firms have also recently issued reports on AMS. N+1 Singer downgraded Advanced Medical Solutions Group plc to a sell rating in a report on Wednesday, September 13th. Numis Securities Ltd reiterated a hold rating and issued a GBX 275 ($3.70) target price on shares of Advanced Medical Solutions Group plc in a report on Wednesday, September 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of GBX 263.20 ($3.54).
Shares of Advanced Medical Solutions Group plc (LON AMS) traded up 0.26% on Wednesday, hitting GBX 289.75. The stock had a trading volume of 120,682 shares. The company’s market cap is GBX 610.90 million. The stock has a 50 day moving average price of GBX 309.40 and a 200-day moving average price of GBX 281.39. Advanced Medical Solutions Group plc has a 12-month low of GBX 198.10 and a 12-month high of GBX 329.50.
The business also recently declared a dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, September 28th will be given a GBX 0.35 ($0.00) dividend. This represents a yield of 0.12%. The ex-dividend date is Thursday, September 28th.
About Advanced Medical Solutions Group plc
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials.
Receive News & Ratings for Advanced Medical Solutions Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group plc and related companies with our FREE daily email newsletter.